Stage
Acquired Unit | AcquiredAbout Stryker - Juvenile Tumour System
On June 13th, 2022, Stryker - Juvenile Tumour System was acquired by Onkos Surgical. Terms of the transaction were not disclosed. Stryker (NYSE: SYK) is a medical technology company that offers a diverse array of products and services in Orthopedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.
Missing: Stryker - Juvenile Tumour System's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Stryker - Juvenile Tumour System's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Stryker - Juvenile Tumour System Frequently Asked Questions (FAQ)
Where is Stryker - Juvenile Tumour System's headquarters?
Stryker - Juvenile Tumour System's headquarters is located at 2825 Airview Blvd, Kalamazoo.
What is Stryker - Juvenile Tumour System's latest funding round?
Stryker - Juvenile Tumour System's latest funding round is Acquired Unit.
Who are the investors of Stryker - Juvenile Tumour System?
Investors of Stryker - Juvenile Tumour System include Onkos Surgical.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.